Several April releases seem to signal some basis for optimism for stakeholders in Medicare Advantage and Part D, though with sufficient undertones to recommend caution. Of particular note, the CY 2026 ...
Among other provisions, the Rate Announcement includes the following updates: MA Payment Changes/Growth Rates: The effective growth rate for 2025 MA non-end-stage renal disease (ESRD) rates is 2.33%.
While technical in nature, risk adjustment is crucial to the future of health care transformation... If reforms to risk adjustment are to succeed, all of us concerned with the future of our health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results